19690342

Source:http://linkedlifedata.com/resource/pubmed/id/19690342

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0009247, umls-concept:C0032659, umls-concept:C0071097, umls-concept:C0289313, umls-concept:C0441471, umls-concept:C1527178, umls-concept:C1705938, umls-concept:C2709058
pubmed:dateCreated	2009-8-19
pubmed:abstractText	To compare the risk of acute myocardial infarction, heart failure, and death in patients with type 2 diabetes treated with rosiglitazone and pioglitazone.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-10189532, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-11874939, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-11952022, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-12177647, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-12588209, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-12962163, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-15111519, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-15295047, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-15655432, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-15845982, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-15956187, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-15963388, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-15983299, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-16007095, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-16026362, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-16214598, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-16510739, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17517853, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17551159, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17551162, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17674425, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17687124, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17848652, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17848653, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17848659, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-17905165, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-18073359, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-18613215, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-18644075, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-18684530, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-18781598, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-19690344, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-19808816, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-20157125, http://linkedlifedata.com/resource/pubmed/commentcorrection/19690342-9454824
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8900488
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone, http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
pubmed:status	MEDLINE
pubmed:issn	1468-5833
pubmed:author	pubmed-author:AustinPeter CPC, pubmed-author:GomesTaraT, pubmed-author:HuxJanet EJE, pubmed-author:JuurlinkDavid NDN, pubmed-author:LipscombeLorraine LLL, pubmed-author:MamdaniMuhammad MMM
pubmed:issnType	Electronic
pubmed:volume	339
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	b2942
pubmed:dateRevised	2010-9-27
pubmed:meshHeading	pubmed-meshheading:19690342-Aged, pubmed-meshheading:19690342-Cohort Studies, pubmed-meshheading:19690342-Diabetes Mellitus, Type 2, pubmed-meshheading:19690342-Female, pubmed-meshheading:19690342-Heart Failure, pubmed-meshheading:19690342-Humans, pubmed-meshheading:19690342-Hypoglycemic Agents, pubmed-meshheading:19690342-Male, pubmed-meshheading:19690342-Myocardial Infarction, pubmed-meshheading:19690342-Retrospective Studies, pubmed-meshheading:19690342-Risk Factors, pubmed-meshheading:19690342-Thiazolidinediones, pubmed-meshheading:19690342-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study.
pubmed:affiliation	Division of Clinical Pharmacology and Toxicology, Department of Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. dnj@ices.on.ca
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't